Janssen Submits Application Seeking Approval of Sirukumab in United States for Rheumatoid Arthritis

HORSHAM, Pa.--(BUSINESS WIRE) September 23, 2016 --Janssen Biotech, Inc. (Janssen) announced today the submission of a Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) seeking approval of sirukumab...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news